Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-10-05
1991-02-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544255, 544278, C07D49504, A61K 31505
Patent
active
049944649
ABSTRACT:
Certain piperazinylpyrimidines have pronounced .beta.-adrenergic blocking properties and some of the compounds are particularly useful in the treatment of elevated intraocular pressure and glaucoma.
REFERENCES:
patent: 3272811 (1966-09-01), Ohnacker et al.
patent: 3311623 (1967-03-01), Ohnacker et al.
patent: 3318881 (1967-05-01), Ohnacker et al.
patent: 3318883 (1967-05-01), Ohnacker et al.
patent: 4889856 (1989-12-01), Tolman et al.
Baldwin John J.
Pietruszkiewicz Adolph
Tolman Richard L.
Wagner Arthur F.
Bernhardt F.
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
Shah Mukund J.
LandOfFree
Piperazinylpyrimidines as .beta.-adrenergic receptor blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinylpyrimidines as .beta.-adrenergic receptor blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinylpyrimidines as .beta.-adrenergic receptor blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143864